Skip to main content

Growth and Development

34
Publications
73.53
%Q1
142
Number of citations
82.61
% Open Access Publications
7
Ongoing Projects
0
Number of Presented Theses
20
Number of Active Clinical Trials
We are a multidisciplinary group of paediatricians and biologists dedicated to clinical and translational research in rare respiratory and endocrinology pediatric diseases and common chronic diseases like asthma, diabetes, and obesity. We also investigate neonatal nutrition and pediatric imaging. Our translational research led, in 2024, to important contributions to international guidelines for cystic fibrosis standards of care and transition of adolescents with interstitial lung diseases, as well as clinical trials of new treatments for asthma and congenital adrenal hyperplasia. We have conducted several studies on the clinical and molecular characterization of rare respiratory and endocrinological diseases. We have also performed other studies on asthma and allergies, diagnosing and treating newborn infants and central nervous system imaging studies.  

eCORE

  • Woman & Child Health & Rare Diseases

Team

Group Leader
Antonio Moreno Galdó

Principal Investigator (PI)
Silvia Gartner, Inés Mir Messa, Diego Yeste Fernández, María Clemente León, Núria Camats Tarruella, Ana Díez Izquierdo, Teresa Garriga Baraut

Researchers
Sandra Rovira Amigo, Alba Torrent-Vernetta, Félix Castillo Salinas, Elida Vázquez Méndez, Mónica Fernández Cancio, Noelia Baz Redón, Ariadna Campos Martorell, Eduard Mogas Viñas

PhD Students
Cristina Aguilar Riera, Nuria González Llorens, Pamela Patricia Yesquen Salcedo, Ignacio Iglesias Serrano

Nursing and Technical Staff
Maria Carmen Soto Pérez

Selected Publications

Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, Clemente M, Fechner PY, Vogiatzi MG, Speiser PW, Auchus RJ, Rosales GBG, Roberts E, Jeha GS, Farber RH, Chan JL
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
N Engl J Med. 2024 Aug 8;391(6):493-503
DOI: 10.1056/NEJMoa2404655
IF: 96.3

Bacharier LB, Maspero JF, Katelaris CH, Fiocchi AG, Gagnon R, de Mir I, Guilbert TW, Jackson DJ, Staudinger HW, Laws E, Mannent LP, Akinlade B, Maloney J, Tawo K, Khokhar FA, Li N, Hardin M, Abdulai RM, Lederer DJ, Robinson LB, Bacharier LB, Maspero JF, Katelaris CH, Fiocchi AG, Gagnon R, De Mir I, Guilbert TW, Jackson DJ, Staudinger HW, Laws E, Mannent LP, Akinlade B, Maloney J, Tawo K, Khokhar FA, Li N, Hardin M, Abdulai RM, Lederer DJ, Robinson LB
Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION): an open-label extension study.
Lancet Respir Med. 2024 Jan;12(1):45-54.
DOI: 10.1016/S2213-2600(23)00303-X.
IF: 38.7

Raidt J, Riepenhausen S, Pennekamp P, Olbrich H, Amirav I, Athanazio RA, Aviram M, Balinotti JE, Bar-On O, Bode SF, Boon M, Borrelli M, Carr SB, Crowley S, Dehlink E, Diepenhorst S, Durdik P, Dworniczak B, Emiralioglu N, Erdem E, Fonnesu R, Gracci S, Grosse-Onnebrink J, Gwozdziewicz K, Haarman EG, Hansen CR, Hogg C, Holgersen MG, Kerem E, Korner RW, Kotz K, Kouis P, Loebinger MR, Lorent N, Lucas JS, Maj D, Mall MA, Marthin JK, Martinu V, Mazurek H, Mitchison HM, Nothe-Menchen T, Ozcelik U, Pifferi M, Pogorzelski A, Ringshausen FC, Roehmel JF, Rovira-Amigo S, Rumman N, Schlegtendal A, Shoemark A, Sperstad Kennelly S, Staar BO, Sutharsan S, Thomas S, Ullmann N, Varghese J, von Hardenberg S, Walker WT, Wetzke M, Witt M, Yiallouros P, Zschocke A, Zietkiewicz E, Nielsen KG, Omran H
Analyses of 1,236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations.
Eur Respir J. 2024 Aug 8;64(2):2301769
DOI: 10.1183/13993003.01769-2023.
IF: 17

Pohunek P, Manali E, Vijverberg S, Carlens J, Chua F, Epaud R, Gilbert C, Griese M, Karadag B, Kerem E, Koucky V, Nathan N, Papiris S, Terheggen-Lagro S, Plch L, Vernetta AT, Bush A
ERS statement on transition of care in childhood interstitial lung diseases.
Eur Respir J. 2024 Aug 15;64(2):2302160
DOI: 10.1183/13993003.02160-2023.
IF: 17

Gramegna A, Addy C, Allen L, Bakkeheim E, Brown C, Daniels T, Davies G, Davies JC, De Marie K, Downey D, Felton I, Hafkemeyer S, Hamouda S, Kendall V, Lindberg U, Macek M, Mayell S, Pearlsman O, Schechter MS, Salvatori L, Sands D, Schwarz C, Shteinberg M, Taylor J, Taylor-Cousar JL, Taylor-Robinson D, Watkins B, Verkleij M, Bevan A, Castellani C, Drevinek P, Gartner S, Lammertyn E, Landau EEC, Middleton PG, Plant BJ, Smyth AR, van Koningsbruggen-R, Burgel PR, Southern KW
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life.
J Cyst Fibros. 2024 May 23:S1569-1993(24)00070-5.
DOI: 10.1016/j.jcf.2024.05.007.
IF: 5.4

Selected Projects

Primary ciliary dyskinesia in adult bronchiectasis. Diagnostic strategy based on next generation sequencing gene panel analysis.
Principal Investigator: Antonio Moreno Galdó
Agency: Instituto de Salud Carlos III
Funding: 134,915 €
Period: 01/01/2021 - 30/06/2025

Improving the diagnosis of primary ciliary dyskinesia
Principal Investigator: Antonio Moreno Galdó
Agency: Asociación Española de Pediatría (AEP)
Funding: 25,500 €
Period: 31/07/2021-30/07/2025

Effectiveness of a high-intensity interval training program in children and adolescents with post-infectious bronchiolitis obliterans: a randomized controlled trial (PIBOHIIT)
Principal Investigator: Ana Díez Izquierdo
Agency: Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
Funding: 16,740 €
Period: 15/07/2023 - 15/07/2024

Support Platform for Clinical Research
Principal Investigator: Inmaculada Fuentes Camps
Agency: Instituto de Salud Carlos III
Funding: 274,920 €
Period: 01/01/2024 - 31/12/2026

Continued Research Capacity (CRC)
Principal Investigator: Silvia Gartner
Agency: European Cystic Fibrosis Society
Funding: 25,500 €
Period: 01/01/2021 - 30/09/2024

VHIR Annual Report 2024